The following pages link to Tim Friede (Q84852):
Displaying 50 items.
- Burak Kürsad Günhan (Q84850) (← links)
- Design and analysis of three-arm trials with negative binomially distributed endpoints (Q84853) (← links)
- Planning and analysis of three-arm non-inferiority trials with binary endpoints (Q84864) (← links)
- A studentized permutation test for three-arm trials in the ‘gold standard’ design (Q84866) (← links)
- Random‐effects meta‐analysis of few studies involving rare events (Q116074) (← links)
- (Q198846) (redirect page) (← links)
- (Q588407) (redirect page) (← links)
- Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials (Q1658139) (← links)
- On the role of data, statistics and decisions in a pandemic (Q2081026) (← links)
- Subgroup identification in individual participant data meta-analysis using model-based recursive partitioning (Q2103863) (← links)
- Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors (Q2233150) (← links)
- Evidence synthesis for count distributions based on heterogeneous and incomplete aggregated data (Q2792770) (← links)
- Blinded and unblinded internal pilot study designs for clinical trials with count data (Q2857492) (← links)
- Do we consent to rules of consent and confidentiality? (Q2980216) (← links)
- Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations (Q2980231) (← links)
- Contribution to the discussion of “When should meta‐analysis avoid making hidden normality assumptions?” A Bayesian perspective (Q4622553) (← links)
- A Bootstrap Procedure for Adaptive Selection of the Test Statistic in Flexible Two-Stage DesignsThis paper is based on a presentation given at the Workshop “Frontiers in Adaptive Designs”, 17.–18. 5. 2001, Vienna/Austria. (Q5121860) (← links)
- A Comparison of Procedures for Adaptive Choice of Location Tests in Flexible Two-Stage Designs (Q5122370) (← links)
- Sample Size Recalculation in Internal Pilot Study Designs: A Review (Q5122838) (← links)
- Blinded Sample Size Reestimation in Non‐Inferiority Trials with Binary Endpoints (Q5122986) (← links)
- A Comparison of Methods for Adaptive Treatment Selection (Q5123111) (← links)
- Adaptive seamless clinical trials using early outcomes for treatment or subgroup selection: Methods, simulation model and their implementation in R (Q5135525) (← links)
- Sample size recalculation in multicenter randomized controlled clinical trials based on noncomparative data (Q5135527) (← links)
- Semi‐parametric analysis of overdispersed count and metric data with varying follow‐up times: Asymptotic theory and small sample approximations (Q5208144) (← links)
- Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases (Q5280181) (← links)
- Dose‐finding methods for Phase I clinical trials using pharmacokinetics in small populations (Q5280197) (← links)
- A note on change point estimation in dose-response trials (Q5941551) (← links)
- Survival analysis for AdVerse events with VarYing follow-up times (SAVVY)—estimation of adverse event risks (Q5975311) (← links)
- Using the bayesmeta R package for Bayesian random-effects meta-regression (Q5975681) (← links)
- Design aspects of COVID‐19 treatment trials: Improving probability and time of favorable events (Q6068480) (← links)
- Adjusting for Publication Bias in Meta-Analysis via Inverse Probability Weighting Using Clinical Trial Registries (Q6079693) (← links)
- Improving adaptive seamless designs through Bayesian optimization (Q6089921) (← links)
- Bounds for the weight of external data in shrinkage estimation (Q6091687) (← links)
- Exact change point detection with improved power in small‐sample binomial sequences (Q6091720) (← links)
- Survival analysis for AdVerse events with VarYing follow‐up times (SAVVY): Rationale and statistical concept of a meta‐analytic study (Q6091730) (← links)
- A studentized permutation test in group sequential designs (Q6531220) (← links)
- Blinded sample size recalculation in adaptive enrichment designs (Q6550297) (← links)
- Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments (Q6572271) (← links)
- A conditional error function approach for adaptive enrichment designs with continuous endpoints (Q6624677) (← links)
- On the role of benchmarking data sets and simulations in method comparison studies (Q6625370) (← links)
- Model averaging for robust extrapolation in evidence synthesis (Q6625672) (← links)
- Summarizing empirical information on between-study heterogeneity for Bayesian random-effects meta-analysis (Q6625784) (← links)
- Sample size re-estimation for clinical trials with longitudinal negative binomial counts including time trends (Q6625972) (← links)
- Blinded sample size reestimation for negative binomial regression with baseline adjustment (Q6627398) (← links)
- Adaptive trial designs in diagnostic accuracy research (Q6627472) (← links)
- Sample size calculation for the augmented logrank test in randomized clinical trials (Q6628399) (← links)
- A straightforward meta-analysis approach for oncology phase I dose-finding studies (Q6628513) (← links)
- Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials (Q6629853) (← links)
- A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules (Q6629855) (← links)
- Blinded continuous monitoring of nuisance parameters in clinical trials (Q6637663) (← links)
